You're a Baby Boomer with a history of smoking, and although you don't have any symptoms, you're afraid of the big C. Instead of just crossing your fingers, why not take the test that can give the early detection that just might save you?
Still, 25% of all cancer deaths are due to lung cancer, and more people die from lung cancer than breast, prostate and colorectal cancer combined, says Rebecca Siegel, lead author of the American Cancer Society’s report. “We have made great progress,” says Ms. Siegel, the strategic director of surveillance information services at the American Cancer Society. “But the number of deaths from lung cancer is still shocking.”
Research over the last decade has catapulted us to within making lung cancer a manageable disease. That’s closer than ever. Most every doctor and researcher I speak with agrees, and they are starting to believe a cure may one day be possible.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the leading cause of cancer-related death world wide. Early diagnosis and treatment provide the best opportunity for survival, but the prognosis becomes increasingly poor as the cancer spreads. Unfortunately, in the majority of cases, by the time symptoms appear and a diagnosis is made, the cancer has already begun to spread.
Odds of survival can greatly improve for people with the most common type of lung cancer if they are given a new drug that activates the immune system along with chemotherapy, a major new study has shown.
The findings, medical experts say, should change the way doctors treat lung cancer: Patients with this form of the disease should receive immunotherapy as early as possible.
What is it like to live with the No. 1 cancer killer in this country? Three men and women speak about living with lung cancer.
Newer approaches include immune-boosting drugs and treatments targeting genetic traits of tumors.
Doctors across the world are beginning to rely on artificial intelligence algorithms to help accelerate diagnostics and treatment plans, with the goal of making more time to see more patients, with greater precision.
In reality, it is reported that up to 15% of lung cancer patients were never smokers. Fortunately, over the last 10 years, new research, diagnosis and treatment breakthroughs have brought new hope to patients around the world. These advancements include screening for early detection and personalizing therapies.
The latest research on why "anyone with lungs is at risk," and what's being done about it.
Understanding how the disease evolves is the key to stopping it.
Radon exposure is the leading cause of lung cancer in non-smokers. Instead of being worried about airport scanners and pat-downs, perhaps we ought to be paying more attention to ensuring that our homes are as safe as possible!
B vitamins are often sold with the promise of boosting flagging energy levels. But men who smoke might want to skip them, according to a new study in the Journal of Clinical Oncology. While smoking kills some six million people a year, the study found that men who smoked and took large doses of vitamins B6 or B12 significantly increased their risk of lung cancer.
If lung cancer in non-smokers were its own statistical category, it would rank among the top ten deadliest cancers in the US.
Lung cancer is the biggest cancer killer in the country, and almost 90 percent of deaths from this disease are directly attributable to cigarette smoking. Many cancers, such as breast cancer, that were once a death sentence are now treatable, yet lung cancer survival rates remain below 20 percent. A cure may be elusive, but the medical community can stop this disease and eliminate most future lung cancer deaths.
We believe that the key to discovery lies within the patient themselves. Together, with your participation in this lung cancer registry, we can build the knowledge base to enable Researchers and Clinicians to identify and understand the complexities of this disease. Knowledge is power. Be the voice. Thank you for joining us in the ultimate fight against lung cancer.
We are so glad you’re here! We want this page to be your home on the web where you can come to learn about the latest news affecting lung cancer patients, get support from stories shared by other patients, and maybe tell your own.
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment.
We are the international voice of lung cancer patients with organisations in 21 countries
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 3,800 lung cancer specialists in 80 countries.
We are the only national non-profit organization dedicated solely to providing support and advocacy for people living with or at risk for the disease.
Our mission ending injustice and saving lives through an alliance of advocacy, education and support.
Our vision is to reduce lung cancer mortality by at least 50% by 2020.
Lung Cancer Canada is a national charitable organization, which aims to increase awareness for lung cancer, support patients and the individuals who care for them, and provide educational resources to patients, family members, healthcare professionals and the general public.
Lungcancer.org is a program of CancerCare, a national nonprofit organization that provides free, professional support services to anyone affected by lung cancer.
LUNGevity is the nation's leading lung cancer-focused nonprofit.
We are changing outcomes for people with lung cancer through research, education, and support.
The Roy Castle Lung Cancer Foundation is the only charity in the UK wholly dedicated to defeating lung cancer, the biggest cancer killer in the world.
Lung cancer is cancer that starts in the lungs. Cancer is a disease where cancerous cells grow out of control, taking over normal cells and organs in the body.
We focus our resources on providing support for people affected by lung disease today; and work in a variety of ways, including funding world-class research, to bring about positive change, to improve treatment, care and support for people affected by lung disease now and in the future.
We fight cancer... that's all we do. We know you are fighting for your life. Our mission is to arm you with every choice, offer you every chance, and empower you to victory.
Understanding treatment options, accessing new and innovative therapies through clinical trials, as well as understanding the role of supportive care and complementary and alternative medicine are essential.
CDC has a number of programs for preventing and controlling lung cancer, which kills more people than any other type of cancer. Research continues to look for better ways to prevent and control lung cancer.
Lung cancer information centre
The Meso Foundation is the non-profit collaboration of patients and families, physicians, advocates, and researchers dedicated to eradicating the life-ending and vicious effects of mesothelioma.
Information about lung cancer treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Tarceva is a targeted cancer treatment. Unlike many other traditional chemotherapies, Tarceva affects certain cell activities. Tarceva is designed to block tumor cell growth by targeting the protein in your body called the Human Epidermal Growth Factor Receptor 1.